Pilot study for a new oral immunotherapy for peanut allergy

Not Applicable

Completed

• Conditions: Peanut allergy; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12614000919617
• Lead Sponsor: Dr Billy Tao

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Patients who are proven to be allergic to peanut by a positive open food challenge test immediately prior to enrolment into the study.

Exclusion Criteria

1. Serious medical co-morbidities.
2. Initial allergic reaction to peanut was life threatening.
3. Parents unable to supervise treatment or unwilling to sign informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified